Company: Sinopharm Group Company Limited
Bloomberg ticker: 1099 HK
Market cap: US$8,554m
Background: Sinopharm Group Company Limited is the largest pharmaceutical distributor in China by revenue. It researches and develops, manufactures and markets medicines, ranging from traditional Chinese medicines to prescription and over-the-counter healthcare products and medical devices. The company serves hospitals, clinics, and drug stores.
World Class Benchmarking of Sinopharm Group
(Click on image to enlarge)
- Profitable Growth rank of 8 was same compared to the prior period’s 8th rank
- This is below average performance compared to 380 large Health Care companies worldwide
- Profitability rank of 8 was worse than its Growth rank of 5
- Profitability rank of 8 was the same compared to the prior period’s 8th rank
- This is below average performance compared to peers
- Growth rank of 5 was up compared to the prior period’s 6th rank
- This is average performance compared to peers
More By This Author:
European Stock: Prada SpA
European Stock: Burberry Group
European Stock: Kering SA
Comments
Log in or sign up to join the conversation.